| FAAIX | RIDAX | FAAIX / RIDAX | |
| Total Expense Ratio | 0.67 | 1.34 | 50% |
| Annual Report Gross Expense Ratio | 0.70 | 1.34 | 52% |
| Fund Existence | 17 years | 24 years | - |
| Gain YTD | 18.791 | 8.784 | 214% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.71B | 140B | 6% |
| Annual Yield % from dividends | 1.64 | 2.82 | 58% |
| Returns for 1 year | 14.03 | 8.07 | 174% |
| Returns for 3 years | 42.54 | 24.61 | 173% |
| Returns for 5 years | 32.92 | 24.14 | 136% |
| Returns for 10 years | 89.66 | 46.58 | 192% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MCYAX | 13.08 | 0.06 | +0.46% |
| NYLI Candriam Emerging Markets Eq Cl A | |||
| GMHPX | 11.96 | 0.05 | +0.42% |
| Goldman Sachs Rising Dividend Gr P | |||
| GSPAX | 18.38 | 0.05 | +0.27% |
| Goldman Sachs US Eq Div and Premium A | |||
| PABGX | 205.12 | 0.42 | +0.21% |
| T. Rowe Price Blue Chip Growth Advisor | |||
| NRIAX | 22.42 | 0.03 | +0.13% |
| Nuveen Real Asset Income A | |||